
30
© 2025 KPMG Advisory (China) Limited, a limited liability company in Chinese Mainland and a member firm of the KPMG global organisation of independent member firms affiliated
with KPMG International Limited, a private English company limited by guarantee. All rights reserved.
Beauty brands are adopting a multi-category strategy, and luxury players are tapping the beauty
market.
•The luxury industry has embarked on a diversification journey. According to the 2024 Global Luxury Market
Research report, due to macro-economic uncertainty and frequent price hikes by luxury brands, the global
personal luxury market will soon experience its first slowdown since the Great Depression. Luxury
companies that have been impacted by consumer market conditions have begun to gradually expand their
brand coverage by widening their presence in lower-tier markets. For example, in 2025, Louis Vuitton
announced it was entering the beauty sector with a new beauty brand called La Beauté Louis Vuitton
featuring 55 lipsticks, 10 lip balms, and 8 palettes81. With this diversification strategy, the company is
offering profitable beauty products to absorb cyclical risks inherent in its core business.
•Beauty players are diversifying in pursuit of a second growth curve.
- In 2025, beauty giants have been expanding into the medical beauty sector, with a focus on medical
beauty devices. For example, Marubi has increased its investment in medical beauty, with plans to
launch three types of medical devices in 2026, including collagen-containing water needles. Other
beauty companies are also launching microneedles amid intense competition in the beauty market.
Consumer demand for effective skincare and absorption continues to grow, and transdermal
absorption has become an important trend in the personal care market. Moreover, the current
microneedle market is relatively small, presenting significant potential.
-Beauty enterprises have begun to expand their product portfolio to categories such as personal care
and perfume to enhance their brand impact. For example, Florasis has moved into the skincare
category with new offerings like skincare essences84. In order to diversify, Chinese beauty brands such
as Maogeping and Han Shu have also entered the perfume business.
•The beauty sector has been active in the capital market, with synthetic biology gaining momentum among
investors. In 2025 H1, international beauty brands accelerated their integration efforts, giving a boost to
local investors. From an investment perspective, synthetic biology, biotech, and efficacy R&D gained
popularity. According to CBO data, financing deals were made by Chinese brands in sub-sectors such as
personal care, functional skincare, pure beauty, body care, pet grooming, and beauty shop brands. With
“effectiveness” becoming a buzzword among investors, they took a growing interest in functional
makeup brands.
Natural products find favour, and innovation is driving development for the sector
•For the cosmetics industry, innovation is about raw materials. With competition intensifying in the beauty
and personal care market, raw materials and products are iterating at a faster pace. However, cosmetics
featuring unique raw materials are more likely to gain popularity. Chinese consumers have a strong
demand for emerging natural and plant-based raw materials; but in the past, regulatory systems have
lagged in terms of technical requirements, guidance, formulation of standards, and innovation of new raw
materials. On 6 February 2025, the National Medical Products Administration issued Several Provisions on
Supporting Innovation in Raw Materials for Cosmetics (Provisions), with the aim of encouraging innovation
in raw materials, improving the mechanism for cosmetics innovation, and optimising management
measures and technical requirements for raw materials.
- The Provisions propose optimising the by-category technology requirements for the registration of new
raw materials. For new raw materials used for the first time domestically and internationally, where a
safety assessment has been conducted, the enterprise may be exempt from long-term clinical trials,
and the filing period will also be shortened, reducing costs for enterprises.
- The Provisions propose allowing simultaneous filings for new raw materials and related products under
a priority evaluation mechanism to accelerate innovation and commercialisation. With this provision,
new ingredients can enter the safety monitoring period more efficiently, shortening the R&D-testing-
review cycle.
-The policy will encourage enterprises to enhance research and innovation in new raw materials,
explore new technologies and methods, introduce safer and more efficient new raw materials, and
reduce the risk of bottlenecks associated with key ingredients, while also encouraging cosmetics
enterprises to seize opportunities through differentiation.
•“Light fitness” is an important trend in health consumption, and it aligns with today’s relaxed and efficient
approach to health management. Nowadays, people are living fast-paced lives and face pressure at work.
Consumers are more likely to suffer from sub-health conditions such as skin and stomach problems. They
prefer a lightweight and fragmented approach to health management, and focus on what they can get
from their efforts. They hope to see results within a specific timeframe and maintain a healthy lifestyle.
-In line with the light fitness concept, consumers prefer products that are health-preserving, natural,
pure, and soothing. Their desire to improve their diet inclines them towards “additive-free” and
“environmentally certified” goods. In this context, natural raw materials are being applied in medical
beauty, cosmetics, and functional food products at a quicker pace, promoting efficacy-focused
innovation in the health industry.
-According to Statista, the global natural cosmetics market will be worth USD 5.93 billion in 2025, and it
is expected to reach USD 7.88 billion in 2029, reflecting an increase of 33% compared to 2025. Amid
an expanding natural product market, consumer products enterprises need to accelerate R&D and
innovation to seize a greater share of the health market.